Hildebrandt Gerhard C, Granell Miguell, Urbano-Ispizua Alvaro, Wolff Daniel, Hertenstein Bernd, Greinix Hildegard T, Brenmoehl Julia, Schulz Christian, Dickinson Anne M, Hahn Joachim, Rogler Gerhard, Andreesen Reinhard, Holler Ernst
Department of Hematology and Oncology, University of Regensburg Medical School, Regensburg, Germany.
Biol Blood Marrow Transplant. 2008 Jan;14(1):67-74. doi: 10.1016/j.bbmt.2007.09.009.
Bronchiolitis obliterans (BO) is a serious complication after allogeneic stem cell transplantation. We hypothesized that single nucleotide polymorphisms (SNPs) of the NOD2/CARD15 gene (=NOD2/CARD15 variants) contribute to changes in host defense and subsequent alloreaction, leading to BO. We analyzed 427 donor-recipient pairs for the association of NOD2/CARD15 variants (SNP8 [Arg702Trp], SNP12 [Gly908Arg], and SNP13 [Leu1007fsinsC]) with BO occurrence. Overall, 11 patients (2.6%) developed BO. The cumulative incidence of BO rose from 1.3% in donor-recipient pairs without mutation to 18.7% in pairs with donor or recipient NOD2/CARD15 variants (P < .001). Recipient NOD2/CARD15 variants alone led to BO in 22.3% (P < .001), whereas donor variants alone associated with BO in 13.2% (P = .04). Multivariate analysis proved recipient but not donor NOD2/CARD15 variants to be a novel independent risk factor for BO development, and NOD2/CARD15 typing may help identify patients at increased risk for BO.
闭塞性细支气管炎(BO)是异基因干细胞移植后的一种严重并发症。我们推测NOD2/CARD15基因的单核苷酸多态性(SNP)(=NOD2/CARD15变异体)会导致宿主防御功能改变及随后的同种异体反应,进而引发BO。我们分析了427对供受者,以研究NOD2/CARD15变异体(SNP8 [Arg702Trp]、SNP12 [Gly908Arg]和SNP13 [Leu1007fsinsC])与BO发生之间的关联。总体而言,11例患者(2.6%)发生了BO。BO的累积发病率从无突变的供受者对中的1.3%升至供者或受者携带NOD2/CARD15变异体的对中的18.7%(P <.001)。仅受者的NOD2/CARD15变异体导致BO的发生率为22.3%(P <.001),而仅供者变异体与BO的关联率为13.2%(P =.04)。多变量分析证明,受者而非供者的NOD2/CARD15变异体是BO发生的一个新的独立危险因素,NOD2/CARD15分型可能有助于识别BO风险增加的患者。